Symptomatic and functional remission in European patients with schizophrenia after paliperidone palmitate treatment (1-month and 3-month formulations)

被引：0
|
作者：
Savitz, A. [1 ]
Xu, H. [2 ]
Gopal, S. [1 ]
Nuamah, I. [2 ]
Hough, D. [1 ]
Hargarter, L. [3 ]
机构：
[1] Janssen Res & Dev, Cent Nervous Syst, Titusville, FL USA
[2] Janssen Res & Dev, Clin Biostats NJ, Titusville, FL USA
[3] Janssen Cilag, Med & Sci Affairs, Neuss, Germany
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2016年 / 26卷
关键词：
D O I：
10.1016/S0924-977X(16)31590-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.d.029
引用
收藏
页码：S546 / S547
页数：2
相关论文
共 50 条
  • [1] Symptomatic Remission Status in Patients with Schizophrenia Treated with Paliperidone Palmitate (1-month and 3-month formulations)
    Savitz, Adam
    Xu, Haiyan
    Gopal, Srihari
    Nuamah, Isaac
    Hough, David
    Mathews, Maju
    BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 354S - 354S
  • [2] Efficacy and safety of paliperidone palmitate (3-month versus 1-month formulation) in European and non-European patients with schizophrenia
    Savitz, A.
    Xu, H.
    Gopal, S.
    Nuamah, I.
    Ravenstijn, P.
    Hough, D.
    Hargarter, L.
    Fleischhacker, W. W.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S548 - S549
  • [3] Effect of two long-acting treatments, the paliperidone palmitate 1-month and 3-month formulations on caregiver burden in European patients with schizophrenia
    Hargarter, L.
    Gopal, S.
    Xu, H.
    McQuarrie, K.
    Savitz, A.
    Nuamah, I.
    Woodruff, K.
    Mathews, M.
    EUROPEAN PSYCHIATRY, 2017, 41 : S198 - S198
  • [4] Efficacy and Safety of Paliperidone Palmitate (3-Month versus 1-Month formulation) in European and Non-European Patients with Schizophrenia
    Savitz, Adam
    Xu, Haiyan
    Gopal, Srihari
    Nuamah, Isaac
    Ravenstijn, Paulien
    Hough, David
    Hargartar, Ludger
    Fleischhacker, Wolfgang
    BIOLOGICAL PSYCHIATRY, 2017, 81 (10) : S211 - S211
  • [5] COST-EFFECTIVENESS OF PALIPERIDONE PALMITATE 3-MONTH VERSUS 1-MONTH FOR THE TREATMENT OF SCHIZOPHRENIA IN THE UNITED STATES
    Asgharian, A.
    Khushalani, A. S.
    Kremenova, L.
    Karki, S.
    Khan, S.
    Akat, M.
    Magruder, A.
    Blanchette, C. M.
    VALUE IN HEALTH, 2019, 22 : S227 - S227
  • [6] Pharmacokinetic-Pharmacodynamic Characterization of Relapse Risk for Paliperidone Palmitate 1-Month and 3-Month Formulations
    Russu, Alberto
    Savitz, Adam
    Mathews, Maju
    Gopal, Srihari
    Feng, Yu
    Samtani, Mahesh N.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2019, 39 (06) : 567 - 574
  • [7] Symptomatic and functional outcomes after treatment with paliperidone palmitate 3-month formulation for 52 weeks in patients with clinically stable schizophrenia
    Garcia-Portilla, Maria Paz
    Llorca, Pierre-Michel
    Maina, Giuseppe
    Bozikas, Vasilis P.
    Devrimci-Ozguven, Halise
    Kim, Sung-Wan
    Bergmans, Paul
    Usankova, Irina
    Pungor, Katalin
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2020, 10
  • [8] Efficacy and safety of paliperidone palmitate 3-month versus 1-month formulation in patients with schizophrenia: comparison between European and non-European population
    Savitz, Adam J.
    Xu, Haiyan
    Gopal, Srihari
    Nuamah, Isaac
    Ravenstijn, Paulien
    Hough, David
    Hargarter, Ludger
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2019, 15 : 587 - 602
  • [9] Comparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients with schizophrenia
    Turkoz, Ibrahim
    Wong, Joshua
    Chee, Benjamin
    Siddiqui, Uzma
    Knight, R. Karl
    Richarz, Ute
    Correll, Christoph U.
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2023, 13
  • [10] COMPARISON OF PALIPERIDONE PALMITATE 3-MONTH AND PALIPERIDONE PALMITATE 1-MONTH FORMULATION FOR NEGATIVE SYMPTOMS IN SCHIZOPHRENIA: A PHASE 3 NON-INFERIORITY STUDY
    Mathews, Maju
    Gopal, Srihari
    Singh, Arun
    Gogate, Jagadish
    Kim, Edward
    Pungor, Katalin
    SCHIZOPHRENIA BULLETIN, 2018, 44 : S311 - S311
12345